Table 4. Main ARI-Illness outcomes for the MEPARI and MEPARI-2 trials.

ARI-Related Outcome	MEPARI (n = 154)					MEPARI-2 (n = 413)					Pooled MEPARI and MEPARI-2 (n = 562)
	CTL	MBSR	%DR1	EX	%DR1	CTL	MBSR	%DR1	EX	%DR1	CTL	MBSR	%DR1	EX	%DR1
n	51	51		47		138	138		137		189	189		184
Had a ARI (n)	28	21	25	17	34	82	74	10	84	-3	110	95	14	101	6
Total # ARIs	40	27	33	26	29	134	112	16	120	10	174	139	20	146	14
Total Days with ARI	453	257	43	241	42	1210	1045	14	1010	16	1663	1302	22	1241	23
# Viruses identified	20	16	20	8	57	76	65	14	65	14	96	81	16	74	21
Mean ARI Global Severity (AUC) (per person)2	358	144	60	248	31	326	256	21	224	31	334	225	33	230	31
Mean ARI Global Severity (AUC) (per ARI)3	456	271	41	449	1.5	336	315	6	256	24	363	306	16	290	20
Total Days of Missed Work due to ARI	67	16	76	32	48	105	73	30	82	21	172	89	48	114	32
Total # of ARI-Related Healthcare Visits	16	10	38	15	-2	24	22	8	21	12	40	32	20	36	5

ARI = acute respiratory infection; CTL = control; MBSR = mindfulness-based stress reduction; EX = exercise;

Global severity = area under curve, y-axis WURSS-24 daily score, x-axis ARI illness duration

¹%DR = Percent Difference in Rate, calculated as (control rate–intervention rate) / (control rate) *100 (equivalent to relative risk reduction for incidence)

² per person with zeros if the participant did not have an ARI. %DR = Percent Difference, calculated as (control-intervention)/control*100

³ per ARI (no zeros). %D = Percent Difference, calculated as (control-intervention)/control*100.